First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221
Clinical trial NCT02675465 · COMPLETED
Trial details
- NCT number
- NCT02675465
- Sponsor
- Amicus Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2024-08-22
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.